121 related articles for article (PubMed ID: 34439599)
1. Renal Involvement in Hereditary Transthyretin Amyloidosis: An Italian Single-Centre Experience.
Ferraro PM; D'Ambrosio V; Di Paolantonio A; Guglielmino V; Calabresi P; Sabatelli M; Luigetti M
Brain Sci; 2021 Jul; 11(8):. PubMed ID: 34439599
[TBL] [Abstract][Full Text] [Related]
2. Natural course and determinants of short-term kidney function decline in hereditary transthyretin amyloidosis: a French observational study.
Dang J; Segaux L; Moktefi A; Stehlé T; Kharoubi M; El Karoui K; Rémy P; Grimbert P; Plante-Bordeneuve V; Guendouz S; Galat A; Mallet S; Oghina S; Chadha GDS; Zaroui A; Fanen P; Canoui-Poitrine F; Damy T; Audard V
Amyloid; 2023 Mar; 30(1):38-48. PubMed ID: 35848215
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal Manifestations in Hereditary Transthyretin Amyloidosis: a Single-Centre Experience.
Luigetti M; Tortora A; Romano A; Di Paolantonio A; Guglielmino V; Bisogni G; Gasbarrini A; Calabresi P; Sabatelli M
J Gastrointestin Liver Dis; 2020 Sep; 29(3):339-343. PubMed ID: 32919418
[TBL] [Abstract][Full Text] [Related]
4. Pathological spectrum of hereditary transthyretin renal amyloidosis and clinicopathologic correlation: a French observational study.
Dang J; Ferlicot S; Misrahi M; Mussini C; Kounis I; Rémy P; Samuel D; Planté-Bordeneuve V; Adams D; Funalot B; Snanoudj R; Damy T; Moktefi A; Audard V; Zaidan M
Nephrol Dial Transplant; 2023 Aug; 38(9):2019-2030. PubMed ID: 36646436
[TBL] [Abstract][Full Text] [Related]
5. Trajectories of Kidney Function in Patients with ATTRv Treated with Gene Silencers.
Luigetti M; Guglielmino V; Romano A; Sciarrone MA; Vitali F; D'Ambrosio V; Ferraro PM
Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553503
[TBL] [Abstract][Full Text] [Related]
6. Hereditary Transthyretin Amyloidosis and the Impact of Classic and New Treatments on Kidney Function: A Review.
Meléndrez-Balcázar E; Aranda-Vela K; Cervantes-Hernández A; López-Cureño S
Am J Kidney Dis; 2024 Mar; ():. PubMed ID: 38484868
[TBL] [Abstract][Full Text] [Related]
7. Kidney involvement in hereditary transthyretin amyloidosis: a cohort study of 103 patients.
Solignac J; Delmont E; Fortanier E; Attarian S; Mancini J; Daniel L; Ion I; Ricci JE; Robert T; Habib G; Moranne O; Jourde-Chiche N
Clin Kidney J; 2022 Sep; 15(9):1747-1754. PubMed ID: 36003663
[TBL] [Abstract][Full Text] [Related]
8. Familial ATTR amyloidosis: microalbuminuria as a predictor of symptomatic disease and clinical nephropathy.
Lobato L; Beirão I; Silva M; Bravo F; Silvestre F; Guimarães S; Sousa A; Noël LH; Sequeiros J
Nephrol Dial Transplant; 2003 Mar; 18(3):532-8. PubMed ID: 12584275
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus.
Grandis M; Obici L; Luigetti M; Briani C; Benedicenti F; Bisogni G; Canepa M; Cappelli F; Danesino C; Fabrizi GM; Fenu S; Ferrandes G; Gemelli C; Manganelli F; Mazzeo A; Melchiorri L; Perfetto F; Pradotto LG; Rimessi P; Tini G; Tozza S; Trevisan L; Pareyson D; Mandich P
Orphanet J Rare Dis; 2020 Dec; 15(1):348. PubMed ID: 33317601
[TBL] [Abstract][Full Text] [Related]
10. Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy.
Magliano L; Obici L; Sforzini C; Mazzeo A; Russo M; Cappelli F; Fenu S; Luigetti M; Tagliapietra M; Gemelli C; Leonardi L; Tozza S; Pradotto LG; Citarelli G; Mauro A; Manganelli F; Antonini G; Grandis M; Fabrizi GM; Sabatelli M; Pareyson D; Perfetto F; Merlini G; Vita G;
Orphanet J Rare Dis; 2021 Apr; 16(1):163. PubMed ID: 33827635
[TBL] [Abstract][Full Text] [Related]
11. The patient journey toward a diagnosis of hereditary transthyretin (ATTRv) amyloidosis.
Vera-Llonch M; Reddy SR; Chang E; Tarbox MH; Pollock M
Orphanet J Rare Dis; 2021 Jan; 16(1):25. PubMed ID: 33430941
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR) Polyneuropathy: Current Perspectives on Improving Patient Care.
Luigetti M; Romano A; Di Paolantonio A; Bisogni G; Sabatelli M
Ther Clin Risk Manag; 2020; 16():109-123. PubMed ID: 32110029
[TBL] [Abstract][Full Text] [Related]
13. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
[TBL] [Abstract][Full Text] [Related]
14. New simple and quick method to analyze serum variant transthyretins: direct MALDI method for the screening of hereditary transthyretin amyloidosis.
Nomura T; Ueda M; Tasaki M; Misumi Y; Masuda T; Inoue Y; Tsuda Y; Okada M; Okazaki T; Kanenawa K; Isoguchi A; Nakamura M; Obayashi K; Shinriki S; Matsui H; Yamashita T; Ando Y
Orphanet J Rare Dis; 2019 May; 14(1):116. PubMed ID: 31133063
[TBL] [Abstract][Full Text] [Related]
15. Association between hearing loss and hereditary ATTR amyloidosis.
Bartier S; Bodez D; Kharoubi M; Guellich A; Canouï-Poitrine F; Chatelin V; Coste A; Damy T; Béquignon E
Amyloid; 2019 Dec; 26(4):234-242. PubMed ID: 31502881
[No Abstract] [Full Text] [Related]
16. Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights.
Koike H; Katsuno M
Biomedicines; 2019 Feb; 7(1):. PubMed ID: 30764529
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of spot versus 24-hour measures of proteinuria for death, end-stage kidney disease or chronic kidney disease progression.
Ying T; Clayton P; Naresh C; Chadban S
BMC Nephrol; 2018 Mar; 19(1):55. PubMed ID: 29514605
[TBL] [Abstract][Full Text] [Related]
18. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis.
Coelho T; Maurer MS; Suhr OB
Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944
[TBL] [Abstract][Full Text] [Related]
19. ATTRv in Lazio-Italy: A High-Prevalence Region in a Non-Endemic Country.
Luigetti M; Guglielmino V; Antonini G; Casali C; Ceccanti M; Chiappini MG; De Giglio L; Di Lazzaro V; Di Muzio A; Goglia M; Inghilleri M; Leonardi L; Massa R; Pennisi EM; Petrucci A; Proietti E; Rispoli M; Sabatelli M; Di Girolamo M
Genes (Basel); 2021 May; 12(6):. PubMed ID: 34071271
[TBL] [Abstract][Full Text] [Related]
20. Glomerular filtration rate measured by (99m) Tc-DTPA renal dynamic imaging is significantly lower than that estimated by the CKD-EPI equation in horseshoe kidney patients.
Qi Y; Hu P; Xie Y; Wei K; Jin M; Ma G; Li Q; Xu B; Chen X
Nephrology (Carlton); 2016 Jun; 21(6):499-505. PubMed ID: 26517584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
